21153 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from other living beings excluding bacteria and viruses, e.g. protozoa, fungi, plants
AUTOMATED HEART VALVE MANUFACTURING
#2ANTIBODY MOLECULES AND USES THEREOF
#3METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS
#4AUTOMATED HEART VALVE MANUFACTURING
#5METHODS OF ISOLATING ALLERGEN-SPECIFIC ANTIBODIES FROM HUMANS AND USES THEREOF
#6VACCINE COMPOSITIONS AND METHODS OF USING THE SAME
#7COTH3 BINDING AGENTS AND USES THEREOF
#8Automated heart valve manufacturing
#9HUMANISED ANTIBODIES AGAINST PATHOGENIC FUNGI
#10Vaccine for falciparum malaria
#11Automated heart valve manufacturing
#12METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITOR
#13TREATMENT AND CONTROL OF BACTERIAL AND FUNGAL DISEASE IN HONEYBEES
#14Automated heart valve manufacturing devices and methods
#15TREATMENT AND PREVENTION OF MALARIA
#16Antibody molecules and uses thereof
#17IPILIMUMAB VARIANTS WITH ENHANCED SPECIFICITY FOR BINDING AT LOW PH
#18ANTIBODY MOLECULES AND USES THEREOF
#19METHODS FOR IDENTIFYING BETA-GLUCAN BINDING TO IMMUNE CELLS
#20METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS
#21Cancer associated antibody compositions and methods of use
#22Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#23Allergen-specific antibodies
#24Identifying human B cells expressing anti-allergen antibodies
#25Vaccine for falciparum malaria
#26Methods of isolating allergen-specific antibodies from humans and uses thereof
#27METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS
#28COMPOSITIONS AND METHODS FOR REDUCING LOCAL AND SYSTEMIC RISKS OF ENVENOMATION
#29ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF
#30Vaccine compositions and methods of using the same
#31Vaccine for falciparum malaria
#32Methods of treating skin cancer by administering a PD-1 inhibitor
#33Fungal vaccine compositions and methods of use thereof
#34Compositions and methods for detection of malaria biomarkers
#35Anti-malarial compositions
#36COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY
#37PEPTIDES AND BINDING PARTNERS THEREFOR
#38PCA1 PROTEIN AND METHODS OF TREATING PNEUMOCYSTIS PNEUMONIA INFECTION
#39CalA BINDING AGENTS, CalA PEPTIDES AND METHODS OF USE
#40Antibody molecules and uses thereof
#41Anti-viral compositions containing PIKfyve inhibitors and use thereof
#42METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS
#43Methods of treating skin cancer by administering a PD-1 inhibitor
#44Vaccine for falciparum malaria
#45Vaccine for malaria
#46Antibodies directed to ricin toxin
#47PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS
#48Chimeric vaccine against fungal infections
#49Influenza A H7N9 virus therapies
#50Anti-ANGPTL8 antibodies and uses thereof
#51MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE
#52METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES
#53Anti-ricin antibodies and uses thereof
#54Anti-ricin antibodies and uses thereof
#55Anti-malarial compositions
#56Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
#57Peptides and binding partners therefor
#58Vaccines against HPV
#59Anti-malarial compositions
#60Methods for identifying beta-glucan binding to immune cells
#61Compositions and methods for beta-glucan immunotherapy
#62COMPOSITION FOR MODULATING THE EXPRESSION OF CELL ADHESION MOLECULES
#63VACCINES AGAINST HPV
#64Vaccine for malaria
#65IGY COMPOSITION FOR USE IN CELIAC DISEASE
#66Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
#67Pharmaceutical compositions and methods to vaccinate against candidiasis
#68PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS
#69Mammalian receptors as targets for antibody and active vaccination therapy against mold infections
#70Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis
#71COMPOSITION FOR MODULATING THE EXPRESSION OF CELL ADHESION MOLECULES
#72MALARIA VACCINE
#73Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
#74MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS
#75Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
#76Methods for modulating the efficacy of nucleic acid based therapies
#77Antibodies Specific for BET V1 and Use Thereof in the Prevention and Treatment of BET V1- Induced Diseases
#78Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
#79Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
#80Methods for Modulating the Efficacy of Nucleic Acid Based Therapies
#81Composition for modulating the expression of cell adhesion molecules
#82Compositions against chicken coccidiosis
#83Methods for determining clinical response to TNF-alpha and/or JAK inhibitors in subjects with inflammatory diseases
#84Pathogen specific avian antibodies in the neonatal mammal